Free Trial
→ Who are Nvidia’s New Silent Partners? (From Weiss Ratings) (Ad)

15 Healthcare Stocks that Analysts Love in a Post-Pandemic World - 3 of 15

Slide 3
Back to 2
Continue to 4
 
Back to 2
Continue to 4
 

Novo Nordisk A/S (NYSE:NVO)

Consensus Rating
Moderate Buy
Rating Score
2.9
Ratings Breakdown
6 Buy Ratings, 1 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$145.17 (7.6% Upside)

About Novo Nordisk A/S

Novo Nordisk A/S logoNovo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally. It operates in two segments, Diabetes and Obesity Care, and Rare Disease. Read More 
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
9/16/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
9/9/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
8/19/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
8/8/2024BMO Capital MarketsLower Price TargetOutperform ➝ Outperform$170.00 ➝ $160.00
8/5/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
7/1/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
6/25/2024BMO Capital MarketsReiterated RatingOutperform ➝ Outperform$163.00 ➝ $163.00
6/17/2024Cantor FitzgeraldReiterated RatingOverweight ➝ Overweight$160.00 ➝ $160.00
6/10/2024ArgusBoost Price TargetBuy ➝ Buy$125.00 ➝ $160.00
5/30/2024The Goldman Sachs GroupInitiated CoverageBuy$156.00
Slide 3
Back to 2
Continue to 4
 

Who are Nvidia’s New Silent Partners? (Ad)

Nvidia recently became just the third $2 trillion company. But Nvidia can’t do everything by itself.

I call these Nvidia’s “Silent Partners.”

More From MarketBeat
Act by Friday, August 16th, to collect this 22% dividend
Let's do a little math here... To double your money at a 3% rate of return, you would need around 23 years....
Investors Alley | Sponsored
15 Stocks Institutional Investors Are Selling Now
Hedge funds, endowments, and other institutional investors have been selling shares of these 15 stocks in the ...
MarketBeat
Why You Should NOT Trade This Market
You'll be interested in our 5-Day Options Trading Challenge, starting September 23. So, what makes this dif...
InvestorPlace | Sponsored
12 Cannabis Stocks to Buy Now
Slowly and surely the cannabis industry is becoming mainstream. As more states legalize medical and recreation...
MarketBeat
This Crypto Is Set to Explode in September
With thousands of cryptocurrencies out there, it's crucial to focus on the ONE that has the potential to make ...
Crypto 101 Media | Sponsored
7 Technology Stocks That Analysts Love The Most
There are more than 1,100 technology companies traded on public markets in the United States. Many of these co...
MarketBeat